Copyright
        ©The Author(s) 2016.
    
    
        World J Gastroenterol. Jan 7, 2016; 22(1): 326-337
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.326
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.326
		Figure 1 Schematic of adeno-associated virus vectors packaged into adeno-associated virus serotypes 2, 8, and 9 with different promoters used for gene delivery.
		
			 AFPp: Human α-fetoprotein promoter; hTERTp: A truncated human telomerase; CBA: Chicken β-actin; TBG: The liver-specific thyroxine-binding globulin; hAAT: Human α1-antitrypsin.
		
	
- Citation: Wang YG, Huang PP, Zhang R, Ma BY, Zhou XM, Sun YF. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 326-337
- URL: https://www.wjgnet.com/1007-9327/full/v22/i1/326.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i1.326

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                        